Advertisement

Topics

Mylan cuts sales forecast as pricing pressure grows

05:26 EDT 9 Aug 2017 | BioPharmaDive

Delays in winning approval for generic copies of Advair and Copaxone further weighed on the specialty drugmaker's outlook for the year. 

Original Article: Mylan cuts sales forecast as pricing pressure grows

NEXT ARTICLE

More From BioPortfolio on "Mylan cuts sales forecast as pricing pressure grows"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...